RHEA REED: Open Payments
NPI 1730876392 · SALINA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $233 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $137 |
| Janssen Pharmaceuticals, Inc | 1 | $124 |
| ABBVIE INC. | 2 | $105 |
| Alkermes, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $14 |
Products named: FANAPT, INVEGA SUSTENNA, VRAYLAR, ARISTADA, CAPLYTA, INGREZZA, REXULTI.
Industry payments across KS — which companies pay providers there.
